Sio Capital Management as of Dec. 31, 2018
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 67 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amgen (AMGN) | 4.7 | $13M | 67k | 194.65 | |
| Medtronic (MDT) | 4.3 | $12M | 131k | 90.96 | |
| Sanofi-Aventis SA (SNY) | 4.2 | $12M | 268k | 43.41 | |
| Alnylam Pharmaceuticals (ALNY) | 4.1 | $11M | 155k | 72.91 | |
| AmerisourceBergen (COR) | 3.6 | $10M | 134k | 74.40 | |
| Cigna Corp (CI) | 3.6 | $9.9M | 52k | 189.92 | |
| CVS Caremark Corporation (CVS) | 3.4 | $9.5M | 145k | 65.52 | |
| Cardinal Health (CAH) | 3.4 | $9.3M | 209k | 44.60 | |
| Hca Holdings (HCA) | 3.0 | $8.5M | 68k | 124.44 | |
| Gw Pharmaceuticals Plc ads | 3.0 | $8.2M | 84k | 97.39 | |
| Bionano Genomics | 2.7 | $7.5M | 1.4M | 5.24 | |
| Novo Nordisk A/S (NVO) | 2.5 | $6.8M | 147k | 46.07 | |
| Celgene Corporation | 2.4 | $6.6M | 102k | 64.09 | |
| Mei Pharma | 2.3 | $6.3M | 2.4M | 2.64 | |
| Gilead Sciences (GILD) | 2.2 | $6.0M | 97k | 62.55 | |
| Urovant Sciences | 1.9 | $5.3M | 808k | 6.59 | |
| McKesson Corporation (MCK) | 1.9 | $5.1M | 47k | 110.47 | |
| Mylan Nv | 1.9 | $5.1M | 187k | 27.40 | |
| Rigel Pharmaceuticals (RIGL) | 1.8 | $5.0M | 2.2M | 2.30 | |
| Premier (PINC) | 1.8 | $5.0M | 134k | 37.35 | |
| Molina Healthcare (MOH) | 1.8 | $5.0M | 43k | 116.21 | |
| Neurocrine Biosciences (NBIX) | 1.8 | $4.9M | 69k | 71.41 | |
| Viking Therapeutics (VKTX) | 1.8 | $4.9M | 637k | 7.65 | |
| Dicerna Pharmaceuticals | 1.7 | $4.7M | 443k | 10.69 | |
| Humana (HUM) | 1.7 | $4.7M | 16k | 286.45 | |
| Emergent BioSolutions (EBS) | 1.6 | $4.4M | 74k | 59.27 | |
| Penumbra (PEN) | 1.5 | $4.2M | 34k | 122.21 | |
| Foamix Pharmaceuticals | 1.5 | $4.1M | 1.2M | 3.59 | |
| Ra Med Sys | 1.4 | $3.9M | 486k | 7.95 | |
| Smith & Nephew (SNN) | 1.4 | $3.8M | 102k | 37.38 | |
| Align Technology (ALGN) | 1.4 | $3.7M | 18k | 209.45 | |
| Zimmer Holdings (ZBH) | 1.3 | $3.6M | 35k | 103.72 | |
| Becton, Dickinson and (BDX) | 1.3 | $3.6M | 16k | 225.31 | |
| UnitedHealth (UNH) | 1.3 | $3.5M | 14k | 249.10 | |
| Abbott Laboratories (ABT) | 1.3 | $3.5M | 49k | 72.33 | |
| Revance Therapeutics (RVNC) | 1.2 | $3.4M | 168k | 20.13 | |
| Medpace Hldgs (MEDP) | 1.2 | $3.3M | 63k | 52.93 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $3.3M | 30k | 108.90 | |
| Icon (ICLR) | 1.0 | $2.8M | 22k | 129.23 | |
| Osmotica Pharmaceuticals (RVLPQ) | 1.0 | $2.7M | 346k | 7.75 | |
| Bristol Myers Squibb (BMY) | 0.9 | $2.6M | 50k | 51.98 | |
| Sutro Biopharma (STRO) | 0.9 | $2.5M | 282k | 9.02 | |
| Dentsply Sirona (XRAY) | 0.9 | $2.4M | 66k | 37.20 | |
| Catalyst Biosciences | 0.8 | $2.3M | 292k | 7.89 | |
| Hill-Rom Holdings | 0.8 | $2.2M | 25k | 88.57 | |
| Kura Oncology (KURA) | 0.7 | $2.0M | 144k | 14.04 | |
| Vical | 0.7 | $1.9M | 1.6M | 1.18 | |
| Harrow Health (HROW) | 0.7 | $1.9M | 335k | 5.69 | |
| Chemocentryx | 0.7 | $1.8M | 169k | 10.91 | |
| Koninklijke Philips Electronics NV (PHG) | 0.6 | $1.8M | 50k | 35.12 | |
| Alexion Pharmaceuticals | 0.6 | $1.7M | 17k | 97.35 | |
| Logicbio Therapeutics | 0.6 | $1.7M | 159k | 10.40 | |
| Inogen (INGN) | 0.6 | $1.6M | 13k | 124.14 | |
| Cymabay Therapeutics | 0.5 | $1.5M | 187k | 7.87 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $1.4M | 53k | 27.42 | |
| Senseonics Hldgs (SENS) | 0.5 | $1.2M | 480k | 2.59 | |
| Axsome Therapeutics (AXSM) | 0.4 | $1.1M | 381k | 2.82 | |
| Invacare Corporation | 0.4 | $1.1M | 247k | 4.30 | |
| Veracyte (VCYT) | 0.3 | $883k | 70k | 12.58 | |
| Achieve Life Science | 0.3 | $723k | 597k | 1.21 | |
| Pfenex | 0.2 | $681k | 214k | 3.19 | |
| Titan Medical (TMDIF) | 0.2 | $544k | 446k | 1.22 | |
| Affimed Therapeutics B V | 0.2 | $503k | 162k | 3.11 | |
| Conformis | 0.1 | $404k | 1.1M | 0.36 | |
| Immunomedics | 0.1 | $370k | 26k | 14.29 | |
| Actinium Pharmaceuticals | 0.1 | $133k | 340k | 0.39 | |
| Lexicon Pharmaceuticals (LXRX) | 0.1 | $143k | 22k | 6.62 |
